The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from Baseline in Pain Intensity Per Numeric Rating Scale
Timeframe: Baseline, up to 72 weeks
Percent Change from Baseline in Body Weight
Timeframe: Baseline, up to 72 weeks
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or